2023 annual financial data
Processa Pharmaceuticals 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -11,457,061 USD and net income was -11,121,520 USD.
Operating cash flow was -8,063,346 USD.
Get free Processa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,457,061 USD
- Net income
- -11,121,520 USD
- Operating cash flow
- -8,063,346 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Processa Pharmaceuticals financial years